From: Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity
Variables | MILK | NCEP | P between | ||||||
---|---|---|---|---|---|---|---|---|---|
Pre | Post | % | P within | Pre | Post | % | P within | ||
Body weight (kg) | 82.6 ± 10.3 | 81.9 ± 10.4 | −0.8% | 0.003 | 82.8 ± 10.5 | 81.5 ± 10.4 | −1.6% | <0.001 | 0.007 |
Waist circumference (cm) | 102.7 ± 8.4 | 102.8 ± 7.9 | 0.1% | 0.92 | 104.0 ± 9.0 | 101.8 ± 8.3 | −2.1% | 0.004 | 0.03 |
Body mass index (kg/m 2 ) | 31.7 ± 3.3 | 31.4 ± 3.4 | −0.8% | 0.001 | 31.7 ± 3.5 | 31.2 ± 3.4 | −1.6% | <0.001 | 0.007 |
Total cholesterol (mmol/L) | 5.75 ± 0.84 | 5.60 ± 0.87 | −2.6% | 0.39 | 5.87 ± 0.78 | 5.53 ± 0.76 | −5.8% | <0.001 | 0.01 |
VLDL cholesterol (mmol/L) a | 0.55 ± 0.48 | 0.58 ± 0.43 | 5.3% | 0.78 | 0.51 ± 0.32 | 0.47 ± 0.37 | −7.9% | 0.64 | 0.57 |
LDL cholesterol (mmol/L) | 3.94 ± 0.55 | 3.97 ± 0.78 | 0.8% | 0.96 | 4.11 ± 0.71 | 3.98 ± 0.71 | −3.0% | 0.36 | 0.42 |
HDL cholesterol (mmol/L) | 1.27 ± 0.25 | 1.06 ± 0.19 | −16.2% | <0.001 | 1.26 ± 0.20 | 1.08 ± 0.19 | −14.1% | <0.001 | 0.29 |
Total/HDL cholesterol ratio | 4.68 ± 1.10 | 5.42 ± 1.23 | 15.9% | <0.001 | 4.81 ± 1.12 | 5.28 ± 1.24 | 9.9% | <0.001 | 0.26 |
Triglycerides (mmol/L) a | 1.84 ± 0.86 | 1.87 ± 0.92 | 1.9% | 0.77 | 1.78 ± 0.75 | 1.60 ± 0.78 | −10.2% | 0.14 | 0.14 |
VLDL triglycerides (mmol/L) a | 1.35 ± 0.78 | 1.40 ± 0.85 | 3.5% | 0.64 | 1.29 ± 0.69 | 1.16 ± 0.73 | −9.8% | 0.25 | 0.18 |
LDL size (Å) | 256.4 ± 2.8 | 256.3 ± 2.4 | 0.0% | 0.64 | 256.1 ± 2.9 | 256.2 ± 2.6 | 0.0% | 0.74 | 0.59 |
LDL-PPD (Å) | 255.6 ± 2.9 | 255.3 ± 2.7 | −0.1% | 0.45 | 255.2 ± 3.0 | 255.5 ± 3.0 | 0.1% | 0.59 | 0.27 |
Apo A-I (g/L) | 1.52 ± 0.18 | 1.40 ± 0.16 | −7.9% | <0.001 | 1.55 ± 0.17 | 1.36 ± 0.18 | −12.1% | <0.001 | 0.06 |
Apo B (g/L) | 1.11 ± 0.21 | 1.10 ± 0.22 | −1.6% | 0.29 | 1.13 ± 0.19 | 1.07 ± 0.18 | −4.8% | 0.02 | 0.37 |
VLDL apo B (g/L) | 0.16 ± 0.08 | 0.16 ± 0.08 | −0.5% | 0.94 | 0.14 ± 0.06 | 0.13 ± 0.07 | −7.2% | 0.36 | 0.42 |
LDL apo B (g/L) | 0.96 ± 0.15 | 0.94 ± 0.19 | −1.8% | 0.32 | 0.98 ± 0.17 | 0.94 ± 0.15 | −4.4% | 0.06 | 0.53 |
CRP (mg/L) | 2.94 ± 1.80 | 3.19 ± 2.30 | 8.5% | 0.40 | 3.38 ± 2.49 | 3.09 ± 2.33 | −8.8% | 0.21 | 0.15 |
Adiponectine (mmol/L) | 10.52 ± 4.31 | 9.36 ± 4.26 | −11.1% | 0.01 | 10.80 ± 4.47 | 9.36 ± 4.09 | −13.3% | 0.001 | 0.58 |
Endothelin (pg/mL) | 0.65 ± 0.25 | 0.57 ± 0.30 | −11.5% | 0.003 | 0.66 ± 0.35 | 0.55 ± 0.23 | −17.6% | 0.001 | 0.85 |
VCAM-1 (ng/mL) | nd | 655.2 ± 179.4 | nd | 690.7 ± 184.5 | −5.1% | 0.25 | |||
ICAM-1 (ng/mL) | nd | 203.8 ± 48.8 | nd | 193.9 ± 32.6 | 5.1% | 0.22 | |||
E-selectin (ng/mL) | nd | 32.8 ± 15.3 | nd | 30.5 ± 12.3 | 7.5% | 0.51 |